Based on the information available, it is possible for liver damage caused by Lipitor (atorvastatin) to be reversed once the medication is no longer being taken. The liver typically regenerates and heals itself over time if the source of the damage is removed [1]. However, it is important to note that this may not be the case for everyone, and some individuals may experience lasting liver damage.

Lipitor is a statin medication used to lower cholesterol levels. One of the potential side effects of Lipitor is liver damage, although this is rare [2]. The drug's label includes a warning about this risk, and it is recommended that liver function be monitored while taking the medication [3].

If liver damage is suspected, a healthcare provider may order tests to evaluate liver function. If liver damage is confirmed, the first step in treatment is to stop taking Lipitor [1]. In many cases, liver function will return to normal once the medication is discontinued [1].

It is important to note that while Lipitor can cause liver damage, it is a relatively rare side effect. According to DrugPatentWatch.com, Lipitor has been prescribed to millions of patients worldwide and has a well-established safety profile [4]. However, as with any medication, it is important to discuss the potential risks and benefits with a healthcare provider before starting Lipitor or any other medication.

In summary, liver damage caused by Lipitor can be reversed in many cases once the medication is no longer being taken. However, it is important to consult with a healthcare provider if liver damage is suspected or if there are concerns about the potential side effects of Lipitor.

Sources:

1. Mayo Clinic. (2021). Atorvastatin (Oral Route). Retrieved from <https://www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/side-effects/drg-20068855>.
2. Lipitor (Atorvastatin Calcium) Tablets, for Oral Use [Prescribing Information]. (2016). Pfizer Labs. Retrieved from <https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020762s051,020763s043,020764s039lbl.pdf>.
3. U.S. Food and Drug Administration. (2012). Questions and Answers: FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs. Retrieved from <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/questions-and-answers-fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering>.
4. DrugPatentWatch.com. (n.d.). Lipitor (Atorvastatin). Retrieved from <https://www.drugpatentwatch.com/drugs/lipitor>.